Skip to main content

Advertisement

SpringerLink
Log in

Choosing the Optimum Therapy for Older Hypertensive Patients

  • Drug Therapy
  • Published:
Drugs & Aging Aims and scope Submit manuscript

Summary

The older hypertensive patient (≥ 60 years) is at progressive risk of suffering from cardiovascular complications of hypertension (heart attack, congestive heart failure, stroke, occlusive peripheral arterial disease and renal failure). In this age group, hypertension is quantified as a blood pressure equal to or greater than 160/95mm Hg (average of 3 times 3 readings). With an increasing baseline risk, the returns of antihypertensive treatment increase, at least up to the age of 80 years. Prospective therapeutic trials have shown considerable benefits regarding prevention of stroke and congestive heart failure. This particularly applies to thiazide-type diuretics.

Before any treatment is undertaken, the cardiovascular status of the older hypertensive patient should be assessed with utmost care, because target organ damage may turn the normalisation of blood pressure into a disadvantage.

The profiles of currently available drugs are reviewed against the background of aging. There is not yet any firm evidence to support the thesis that some drug classes are better suited than others for treating older hypertensive patients, although some caution with α1-blockers and centrally acting agents seems appropriate. Finally, some practical recommendations are presented on the build-up of optimum therapy in individual patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Amery A, et al. (38 authors). Antihypertensive therapy in patients above 60 years. Current Medical Research and Opinion 8 (Suppl. 1): 5–18, 1982

    Article  Google Scholar 

  • Amery A, Birkenhäger WH, Brixko P, et al. Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly Trial. Lancet 1: 1349–1354, 1985

    Article  PubMed  CAS  Google Scholar 

  • Amery A, Birkenhäger WH, Brixko P, et al. Efficacy of anti-hypertensive drug treatment according ot age, sex, blood pressure, and previous cardiovascular disease in patients over the age of 60. Lancet 2: 589–592, 1986

    Article  PubMed  CAS  Google Scholar 

  • Ames RP. Negative effects of diuretic drugs on metabolic risk factors for coronary heart disease: possible alternative drug therapies. New England Journal of Medicine 307: 976–980, 1982

    Article  Google Scholar 

  • Australian National Blood Pressure Study. Treatment of mild hypertension in the elderly. Medical Journal of Australia 68: 398–402, 1981

    Google Scholar 

  • Bird AS, Blizard RA, Mann AM. Treating hypertension in the older person: an evaluation of the association of blood pressure level and its reduction with cognitive performance. Journal of Hypertension 8: 147–152, 1990

    Article  PubMed  CAS  Google Scholar 

  • Birkenhäger WH, De Leeuw PW. How far should blood pressure be lowered? Drugs 36: 7–10, 1988

    Article  PubMed  Google Scholar 

  • Birkenhäger WH, De Leeuw PW. Cardiovascular perspectives of reducing high blood pressure. Netherlands Journal of Medicine 34: 229–232, 1989

    PubMed  Google Scholar 

  • Birkenhäger WH, De Leeuw PW, Wester A, Kho TL, Vandongen R, et al. Therapeutic effects of β-adrenoceptor blocking agents in hypertension. Advances in Internal Medicine and Pediatrics 39: 117–134, 1977

    PubMed  Google Scholar 

  • Brogdcn RN, Sorkin EM. Ketanserin: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in hypertension and peripheral vascular disease. Drugs 40: 903–949, 1990

    Article  Google Scholar 

  • Bühler FR, Kiowski W. Calcium antagonists in hypertension. Journal of Hypertension 5 (Suppl. 3): S3–S10, 1987

    Article  PubMed  Google Scholar 

  • Bulpitt CJ. Definition, prevalence and incidence of hypertension in the elderly. In Birkenhäger & Reid (Sen. Eds) Handbook of hypertension. Vol. 12 (Eds Amery & Staessen), Hypertension in the elderly. Chap. 13, pp. 153–169, Elsevicr, Amsterdam, 1989

  • Caralis PV, Materson BJ, Perez-Stable E. Potassium and diuretic-induced ventricular arrhythmias in ambulatory hypertensive patients. Mineral and Electrolyte Metabolism 10: 148–154, 1984

    PubMed  CAS  Google Scholar 

  • Carruthers SG. The centrally acting drugs. Journal of Cardiovascular Pharmacology 12 (Suppl. 8): S74–S79, 1988

    PubMed  Google Scholar 

  • Chalmers JP, Smith SA, Wing LHM. Hypertension in the elderly: the role of calcium antagonists. Journal of Cardiovascular Pharmacology 12 (Suppl. 8): S147–S155, 1988

    PubMed  Google Scholar 

  • Cockroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 16: 31–41, 1976

    Article  Google Scholar 

  • Coope J, Warrender TS. Randomized trial of treatment of hypertension in primary care. British Medical Journal 293: 1145–1151, 1986

    Article  PubMed  CAS  Google Scholar 

  • Cooper WD, Sheldon D, Brown D, Kimber GR, Isitt V, et al. Post marketing surveillance of enalapril experience in 11710 hypertensive patients in general practice. Journal of the College of General Practitioners 37: 346–349, 1987

    CAS  Google Scholar 

  • Cruickshank JM, Thorp JM, Zacharias FJ. Benefits and potential harm of lowering high blood pressure. Lancet 1: 581–584, 1987

    Article  PubMed  CAS  Google Scholar 

  • De Leeuw PW, Birkenhäger WH. Renal response to propranolol treatment in hypertensive humans. Hypertension 4: 127–131, 1982

    Google Scholar 

  • De Leeuw PW, Birkenhäger WH. The impact of senescence on the renal vasculature and renin secretion. In Birkenhäger & Reid (Sen. Eds) Handbook of hypertension Vol. 12, (Eds Amery & Staessen), Hypertension in the elderly, Chap. 9, pp. 99–118, Elsevier, Amsterdam, 1989

    Google Scholar 

  • Dubach UC, Metz I, Schmid P. Serum creatinine values in 2258 employed subjects of various ages and sex. Klinische Wochenschrift 45: 621–629, 1967

    Article  PubMed  CAS  Google Scholar 

  • Fitzgerald JD. Age-related effect of β-blockers and hypertension. Journal of Cardiovascular Pharmacology 12 (Suppl. 8): S83–S92, 1988

    PubMed  Google Scholar 

  • Gifford NW. Isolated systolic hypertension in the elderly. Journal of the American Medical Association 247: 781–785, 1982

    Article  PubMed  Google Scholar 

  • Gill JS, Beevers DG, Zezalka AV, Davies P. Relationship between initial blood pressure and its fall with treatment. Lancet 1: 567–569, 1985

    Article  PubMed  CAS  Google Scholar 

  • Goldstein DS. Arterial baroreflex sensitivity, plasma catecholamines, and pressor responsiveness in essential hypertension. Circulation 68: 234–240, 1983

    Article  PubMed  CAS  Google Scholar 

  • Goldstein G, Materson BY, Cushman WC, et al. Treatment of hypertension in the elderly. II. Cognitive and behavioural function — results of a Department of Veterans’ Affairs Cooperative Study. Hypertension 15: 361–369, 1990

    Article  PubMed  CAS  Google Scholar 

  • Gribbin B, Pickering TG, Sleight P, Peto R. Effect of age and high blood pressure on baroreflex sensitivity in man. Circulation Research 29: 424–429, 1971

    Article  PubMed  CAS  Google Scholar 

  • Hollenberg NK, Adams DF, Solomon HS. Senescence and the renal vasculature in normal man. Circulation Research 34: 309–316, 1974

    Article  PubMed  CAS  Google Scholar 

  • Hypertension Detection and Follow-up Program Cooperative Group. Five-year findings of the hypertension detection and follow-up program II: Mortality by race, sex and age. Journal of the American Medical Association 242: 2572–2579, 1979

    Article  Google Scholar 

  • Jansen PAF, Gribnau FWJ, Schulte BPM, Poels EFJ. Contribution of inappropriate treatment for hypertension to pathogencsis of stroke in the elderly. British Medical Journal 293: 914–917, 1986

    Article  PubMed  CAS  Google Scholar 

  • Johnston CI. Angiotcnsin converting enzyme inhibitors. In Birkenhäger & Reid (Sen. Eds) Handbook of hypertension, Vol. 11, Doyle AE (Ed.) Clinical pharmacokinetics of antihypertensive drugs, chap. 9, pp. 301–326, Elsevier, Amsterdam, 1988

    Google Scholar 

  • Joint National Committee. Hypertension prevalence and the status of awareness, treatment, and control in the United States: final report of the subcommittee on definition and prevalence of the 1984

  • Joint National Committee. Hypertension 7: 457–458, 1985

    Google Scholar 

  • Krebs R. Adverse reactions with calcium antagonists. Hypertension 5 (Suppl. 2): S125–S129, 1983

    Google Scholar 

  • Lees KRL, Reid JL. Age and the pharmacokinetics and pharmacodynamics of chronic enalapril treatment. Clinical Pharmacology and Therapeutics 41: 597–602, 1987

    Article  PubMed  CAS  Google Scholar 

  • Lconetti G. Centrally acting antihypertensive agents. Journal of Cardiovascular Pharmacology 12 (Suppl. 8): S68–S73, 1988

    Google Scholar 

  • Leren P. Helgeland A, Holme I, et al. Effect of propranolol and prazosin on blood lipids: the Oslo study. Lancet 2: 4–6, 1980

    Article  PubMed  CAS  Google Scholar 

  • Lindman RD, Tobin JD, Shock NW. Association between blood pressure and the rate of decline in renal function with age. Kidney International 26: 861–868, 1984

    Article  Google Scholar 

  • Ljunquist A. The intrarenal arterial pattern in the normal and diseased human kidney. Acta Medica Scandinavica (Suppl. 401): 5–38, 1963

  • Luft FC, Grim CE, Finebcrg M. Effects of volume expansion and contraction in normotensive whites, blacks, and subjects of different ages. Circulation 59: 643–650, 1979

    Article  PubMed  CAS  Google Scholar 

  • Management Committee. The Australian therapeutic trial in mild hypertension. Lancet 1: 1261–1267, 1980

    Google Scholar 

  • Man in ’t Veld A, Van den Meiracker AM, Schalekamp MA. Age dependency of blood pressure response to anithypertensive treatment: some methodological considerations and observations of five β-adrenoceptor antagonists under different experimental conditions. Journal of Cardiovascular Pharmacology 12 (Suppl. 8): S93–S97, 1988

    PubMed  Google Scholar 

  • Medical Research Council Working Party on Mild to Moderate Hypertension. MRC trial of mild hypertension: principal results. British Medical Journal 291: 97–104, 1985

    Google Scholar 

  • Messerli FH. Osier’s manoeuver, pseudohypertension, and true hypertension in the elderly. American Journal of Medicine 80: 906–910, 1986

    Article  PubMed  CAS  Google Scholar 

  • Moser M. Diuretics and alternative drugs in geriatric hypertension. Geriatrics 42: 39–44, 1987

    PubMed  CAS  Google Scholar 

  • Myers J, Morgan T, Waga S, Manley K. The effect of sodium intake on blood pressure related to the age of the patients. Clinical Experimental Pharmacology and Physiology 9: 287–289, 1982

    Article  CAS  Google Scholar 

  • Nicholls MG. Age, diuretics and hypertension. Journal of Cardiovascular Pharmacology 12 (Suppl. 8): S52–S59, 1988

    Google Scholar 

  • Oldham PD. A note on the analysis of repeated measurements of subjects. Journal of Chronic Diseases 15: 969–977, 1962

    Article  PubMed  CAS  Google Scholar 

  • PACK Trial. Prevention of atherosclerotic complications: controlled trial of ketanserin. British Medical Journal 298: 424–430, 1989

    Article  Google Scholar 

  • Pollare T, Lithell H, Berne C. A comparison of the effect of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension. New England Journal of Medicine 321: 868–873. 1989

    Article  PubMed  CAS  Google Scholar 

  • Rosendorff C, Murray GD. Ketanserin versus metoprolol and hydrochlorothiazide in essential hypertension: only ketanserin’s effect is age-related. Journal of Hypertension 4 (Suppl. 6): S109–S111, 1986

    Google Scholar 

  • Schalekamp MADH, Krauss XH, Schalekamp-Kuyken MPA, Kolsters G, Birkenhäger WH. Studies on the mechanism of hypernatriuresis in essential hypertension in relation to measurement of plasma renin concentration, body fluid compartments and renal function. Clinical Science 41: 219–231, 1971

    PubMed  CAS  Google Scholar 

  • Shimada K, Kazumi T, Sudakune N, Ogura H, Ozawa T. Age-related changes of baroreflex function, plasma norepinephrine and blood pressure. Hypertension 7: 113–117, 1985

    Article  PubMed  CAS  Google Scholar 

  • Sowers JR. Hypertension in the elderly. American Journal of Medicine 82 (Suppl. 1B): 1–8, 1987

    Article  PubMed  CAS  Google Scholar 

  • Staessen J, Fagard R, Van Hoof R, Amery A. Mortality in various intervention trials in elderly hypertensive patients: a review. European Heart Journal 9: 215–222, 1988

    PubMed  CAS  Google Scholar 

  • Stern N, Beahm E, McGinty D, Eggena P, Littner M, et al. Dissociation of 24-hour catecholamine levels from blood pressure in older men. Hypertension 7: 1023–1029, 1985

    Article  PubMed  CAS  Google Scholar 

  • Stewart DE, Ikram H, Espiner EA, Nicholls MG. Arrhythmogenic potential of diuretic induced hypokalaemia in patients with mild hypertension and ischaemic heart disease. British Heart Journal 54: 290–297, 1985

    Article  PubMed  CAS  Google Scholar 

  • Stokes GS. Age-related effects of antihypertensive therapy with β-blockers. Journal of Cardiovascular Pharmacology12 (Suppl. 8): S109–S115, 1988

    PubMed  Google Scholar 

  • Vanhoutte PM, Amery A, Birkenhäger WH, et al. Serotoninergic mechanisms in hypertension: focus on the effects of ketanserin. Hypertension 11: 111–133, 1988

    Article  PubMed  CAS  Google Scholar 

  • Veterans Administration Cooperative Study Group on antihypertensive agents. Effects of treatment on morbidity in hypertension. III: Influence of age, diastolic pressure and prior cardiovascular disease; further analysis of side effects. Circulation 45: 991–1004, 1972

    Article  Google Scholar 

  • Vokonas PS, Kannel WB, Cupples LA, Epidemiology and risk of hypertension in the elderly: the Framingham Study. Journal of Hypertension 6 (Suppl. 1): S3–S9, 1988

    PubMed  CAS  Google Scholar 

  • Weinberger MH. Antihypertensive therapy and lipids. Evidence, mechanisms and implications. Archives of Internal Medicine 145: 1102–1105, 1985

    Article  PubMed  CAS  Google Scholar 

  • Wollner L, McCarthy ST, Soper NDW, Macy DJ. Failure of cerebral autoregulation as a cause of brain dysfunction in the elderly. British Medical Journal 1: 1117–1118, 1979

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Erasmus University, Karl Marxstraat 35, 3076 D.P., Rotterdam, The Netherland

    W. H. Birkenhäger (Prof.)

Authors
  1. W. H. Birkenhäger
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Birkenhäger, W.H. Choosing the Optimum Therapy for Older Hypertensive Patients. Drugs & Aging 1, 36–47 (1991). https://doi.org/10.2165/00002512-199101010-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002512-199101010-00005

Keywords

Search

Navigation